Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Saved in:
Bibliographic Details
Title: Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.
Authors: Munawar U; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Thurner J; School of Life Sciences, Technical University of Munich, Freising, Germany., Nerreter S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Nerreter T; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Leipold AM; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany., Han S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Verbruggen C; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Gerhard-Hartmann E; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Vogt C; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Grams B; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Kurian S; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Besant E; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Roth S; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Weingart J; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Eiring P; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Truger M; MLL Munich Leukemia Laboratory, Munich, Germany., Afrin N; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany., Steinbrunn T; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Tamamushi Y; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Zhou X; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Rein N; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Lehmann J; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Köppel M; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Rosenwald A; Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Hudecek M; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Saliba AE; Helmholtz Institute for RNA-based Infection Research, Helmholtz Centre for Infection Research, Wuerzburg, Germany.; Institute of Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany., Rasche L; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, Germany., Sauer M; Department of Biotechnology and Biophysics, University of Wuerzburg, Wuerzburg, Germany., Einsele H; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany., Kuster B; School of Life Sciences, Technical University of Munich, Freising, Germany., Waldschmidt J; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany.; INTERACT Advanced Clinician Scientist-Program, University of Wuerzburg, Wuerzburg, Germany., Kortüm KM; Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany. kortuem_m@ukw.de.
Source: Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1227-1239. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-026-02920-7